AstraZeneca prices USD2 billion multi-year bond issuance
(Alliance News) - AstraZeneca PLC on Thursday priced a global bond offering worth USD2 billion. Read More
| Price | 15,306.00p on 26-02-2026 at 10:44:32 |
|---|---|
| Change | 88.00p 0.58% |
| Buy | 15,306.00p |
| Sell | 15,302.00p |
| Last Trade: | Unknown 0.00 at 15,306.00p |
| Day's Volume: | 167,663 |
| Last Close: | 15,218.00p |
| Open: | 15,144.00p |
| ISIN: | GB0009895292 |
| Day's Range | 15,112.00p - 15,330.00p |
| 52wk Range: | 9,574.00p - 15,730.00p |
| Market Capitalisation: | £237.36b |
| VWAP: | 15,224.885p |
| Shares in Issue: | 1.55b |
Astrazeneca (AZN) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Unknown* | 0 | 15,306.00p | SI Trade |
10:44:32 - 26-Feb-26 |
| Sell* | 14 | 15,306.00p | Automatic Execution |
10:44:25 - 26-Feb-26 |
| Buy* | 13 | 15,307.0565p | Ordinary |
10:44:19 - 26-Feb-26 |
| Sell* | 19 | 15,308.00p | Automatic Execution |
10:44:03 - 26-Feb-26 |
| Sell* | 241 | 15,308.00p | Automatic Execution |
10:43:57 - 26-Feb-26 |
| Sell* | 9 | 15,308.00p | Automatic Execution |
10:43:54 - 26-Feb-26 |
| Sell* | 35 | 15,306.6988p | Ordinary |
10:43:46 - 26-Feb-26 |
| Buy* | 15 | 15,308.00p | Automatic Execution |
10:43:45 - 26-Feb-26 |
| Buy* | 17 | 15,308.00p | Automatic Execution |
10:43:45 - 26-Feb-26 |
| Buy* | 48 | 15,308.00p | Automatic Execution |
10:43:45 - 26-Feb-26 |
Astrazeneca (AZN) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 25th Feb 2026 7:00 am | RNS | Filing of Form 20-F with SEC |
| 24th Feb 2026 11:00 am | RNS | Annual Financial Report |
| 24th Feb 2026 7:00 am | RNS | Directorate change |
| 20th Feb 2026 7:00 am | RNS | Fixed-duration Calquence combo approved in US |
| 10th Feb 2026 7:00 am | RNS | Final Results |
| 3rd Feb 2026 7:00 am | RNS | Update on Saphnelo subcutaneous administration |
| 2nd Feb 2026 3:00 pm | RNS | Total Voting Rights |
| 2nd Feb 2026 7:05 am | RNS | Imfinzi recommended in EU for early gastric cancer |
| 2nd Feb 2026 7:00 am | RNS | AstraZeneca begins trading on NYSE |
| 30th Jan 2026 7:00 am | RNS | AstraZeneca agrees obesity and T2D deal with CSPC |